教育背景
2000.9-2005.6中国药科大学药剂学博士(硕博连读);1996.9-2000.7 中国药科大学药物制剂专业学士。
工作经历
2005.7-至今 中国药科大学药剂教研室工作;2012.6-2013.6 美国北卡罗来纳大学教堂山分校访问学者。
项目课题经历
论文、成果、著作等
1.Yuanke Li, Yuanyuan Wu, Leaf Huang, Lei Miao, Jianping Zhou, Andrew Benson Satterlee, Jing Yao*. Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy. J Control Release, 2016, 228:107-119. (IF: 7.705)
2.Hui Xiong, Shi Du, Jiang Ni, Jianping Zhou, Jing Yao*. Mitochondria and Nuclei Dual-targeted Heterogeneous Hydroxyapatite Nanoparticles for Enhancing Therapeutic Efficacy of Doxorubicin. Biomaterials,2016, 94:70-83. (IF: 8.557)
3.Xiaoying Wang,Yihang Chen,Fatima ZohraDahmani,Lifang Yin,Jianping Zhou,Jing Yao*, Amphiphiliccarboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel, Biomaterials, 2014, 35(26): 7654-7665. (IF: 8.557)
4.Jing Yao,Yuan Zhang,SrinivasRamishetti,Yuhua Wang,Leaf Huang, Turning an antiviral agent into an anticancer drug: Nanoparticles delivery of ancyclovir monophosphate, J Control Release, 2013, 170(3): 414-420. (IF: 7.705)
5.Lin Hou#,Jing Yao(#equal contribution),Jianping Zhou,Qiang Zhang, Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system, Biomaterials, 2012, 33 (21): 5431-5440. (IF: 8.557)
专利、著作版权等
声明:本站专家信息来源于各高校官网。